Researchers explore the cellular and molecular adaptations associated with human secondary lymphoid tissue in adults during ...

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide ...

There's currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the ...

Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy in Oncology, today announced the appointment of Elena Garralda, MD, Ph.D., to ...

Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today ...

Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncology ...

Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix ...

AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Produc ...

Cancer therapies do not always succeed in eliminating tumour cells. Some of these cells enter a state of senescence—a latent, ...

Imfinzi recommended for approval in European Union for the treat of adults with limited-stage small cell lung cancer ...

Researchers have identified various distinctive immune cells in cow's milk, creating potential avenues for enhancing animal ...

Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on February 3, 2025, the Compensation Committee of the company’s Board of Directors granted to 18 new employees inducement awards ...